Takeda Chemical Industries
Officials from Takeda Chemical Industries recently report on new developments
Published in Law and Health Weekly, September 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Takeda Chemical Industries.
Report 1: Takeda Pharmaceutical Company Limited ("Takeda") announced today that its investigational compound TAK-491 has entered into Phase 3 clinical stage in the U.S. and Europe. TAK-491 is an angiotensin receptor blocker (ARB) discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II.
TAK-491 is expected to show stronger anti-hypertensive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Aarp
AARP Poll: California Members Want Health Care Reform THIS YEAR - Actavis
Robert Wessman to present at the GPhA's 2007 annual Policy conference - Addiction Medicine
Research from J.P. Wojtowicz and colleagues provide new insights into addiction medicine - AnyDATA Corporation
New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden - Autism
Research from Wayne State University in autism provides new insights - Bioengineering
Research reports from R.H. Dwinger and co-authors provide new insights into bioengineering - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
